세계의 자동 미생물 검사 시장 : 컴포넌트별, 최종 사용자별 예측(2025-2030년)

The Automated Microbiology Market was valued at USD 11.27 billion in 2023, expected to reach USD 12.51 billion in 2024, and is projected to grow at a CAGR of 11.87%, to USD 24.74 billion by 2030.

Automated microbiology refers to the utilization of advanced technologies like AI, robotics, and digital analytics to streamline and enhance microbiological testing and analysis processes. The scope of this field encompasses clinical diagnostics, environmental monitoring, pharmaceutical applications, and food safety testing. Its necessity arises from the need for accurate, efficient, and high-throughput screening techniques that minimize human error and time-consumption. Automated systems help laboratories manage large volumes of tests, reducing manual intervention while increasing precision and reproducibility. The application of automated microbiology spans across various sectors; in healthcare, it aids in pathogen detection and antibiotic susceptibility testing, while in pharmaceuticals, it ensures quality control and contamination checks. Food and beverage industries leverage these techniques to maintain safety and compliance with standards.

Key factors driving market growth include rising demand for rapid diagnostic techniques, increasing prevalence of infectious diseases, and heightened awareness of food safety. Technological advancements in AI and machine learning within the microbiology domain present significant opportunities, as they allow for improved pattern recognition and predictive analytics. To capitalize on these opportunities, businesses should invest in R&D to develop innovative algorithms and invest in collaborations or partnerships that fuse IT expertise with microbiology acumen. Despite the promising outlook, challenges such as high initial investment costs, complex integration processes, and regulatory hurdles could impede market expansion. Another limitation includes the potential for data privacy concerns, particularly in healthcare applications.

Potential areas for innovation include the development of miniaturized and portable diagnostic devices, enhancing the integration capabilities of different automated systems, and improving the speed and accuracy of microbial genome sequencing. Research into bioinformatics and computational microbiology could further drive progress. The nature of the market is dynamic, with opportunities for new entrants that can offer cost-effective, efficient, and adaptable solutions to the current and future needs of the microbiology industry. Detailed strategies that address regulatory compliance and cost management will be crucial to achieving sustained growth and market success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Automated Microbiology Market

The Automated Microbiology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Escalating need for efficient diagnostics to manage growing chronic diseases
  • Increasing demand for rapid microbiological testing methods in food & beverage
• Market Restraints
  • High cost of integration of automated microbiology solutions
• Market Opportunities
  • Growing introduction of technological advanced automated microbiology solutions with enhanced accuracy and efficiency
  • Rising government support for adoption of automated technologies across healthcare and laboratories
• Market Challenges
  • Privacy and security issues with automated microbiology solutions

Porter's Five Forces: A Strategic Tool for Navigating the Automated Microbiology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Automated Microbiology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Automated Microbiology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Automated Microbiology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Automated Microbiology Market

A detailed market share analysis in the Automated Microbiology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Automated Microbiology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Automated Microbiology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Automated Microbiology Market

A strategic analysis of the Automated Microbiology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Automated Microbiology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accelerate Diagnostics, Inc., Agilent Technologies, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company (BD), BIOMERIEUX, bioMerieux Industry, bioMerieux SA, Bruker Corporation, Cepheid Inc., Copan Diagnostics Inc., Danaher Corporation, Hardy Diagnostics, Labcompare, Luminex Corporation, Merck KGaA, Neogen Corporation, PerkinElmer, Inc., QIAGEN N.V., Randox Laboratories Ltd., Siemens Healthineers AG, Sysmex Corporation, T2 Biosystems, Inc., Thermo Fisher Scientific Inc., and Whitelake Software Point Oy.

Market Segmentation & Coverage

This research report categorizes the Automated Microbiology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Component, market is studied across Hardware, Services, and Software. The Hardware is further studied across Automated Incubators, Bacterial Colony Pickers, Imaging Systems, Plate Reader, and Specimen Processors.
• Based on End-User, market is studied across Agriculture, Education & Academic Institutions, Environmental Monitoring, Food & Beverage, Hospital & Clinical Laboratories, and Pharmaceutical & Biotechnology Firms.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Escalating need for efficient diagnostics to manage growing chronic diseases
    • 5.1.1.2. Increasing demand for rapid microbiological testing methods in food & beverage
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of integration of automated microbiology solutions
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing introduction of technological advanced automated microbiology solutions with enhanced accuracy and efficiency
    • 5.1.3.2. Rising government support for adoption of automated technologies across healthcare and laboratories
  • 5.1.4. Challenges
    • 5.1.4.1. Privacy and security issues with automated microbiology solutions
• 5.2. Market Segmentation Analysis
  • 5.2.1. Component: Growing usage of automated microbiology testing software to capture and analyze images of microbial cultures
  • 5.2.2. End-User: High potential of automated microbiology in hospital & clinical laboratories reducing manual errors and improving turnaround times
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Automated Microbiology Market, by Component

• 6.1. Introduction
• 6.2. Hardware
  • 6.2.1. Automated Incubators
  • 6.2.2. Bacterial Colony Pickers
  • 6.2.3. Imaging Systems
  • 6.2.4. Plate Reader
  • 6.2.5. Specimen Processors
• 6.3. Services
• 6.4. Software

7. Automated Microbiology Market, by End-User

• 7.1. Introduction
• 7.2. Agriculture
• 7.3. Education & Academic Institutions
• 7.4. Environmental Monitoring
• 7.5. Food & Beverage
• 7.6. Hospital & Clinical Laboratories
• 7.7. Pharmaceutical & Biotechnology Firms

8. Americas Automated Microbiology Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Automated Microbiology Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Automated Microbiology Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. County Approves Funds to Expand FCPD's Automatic License Plate Reader Program
  • 11.3.2. London's Hospitals Adopting Clinical Microbiology with a World-first Installation of State-of-the-art Automated Laboratory Technology
  • 11.3.3. BD Introduces Fully Automated Robotic Track System for Microbiology Labs
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Accelerate Diagnostics, Inc.
• 3. Agilent Technologies, Inc.
• 4. Beckman Coulter, Inc.
• 5. Becton, Dickinson and Company (BD)
• 6. BIOMERIEUX
• 7. bioMerieux Industry
• 8. bioMerieux SA
• 9. Bruker Corporation
• 10. Cepheid Inc.
• 11. Copan Diagnostics Inc.
• 12. Danaher Corporation
• 13. Hardy Diagnostics
• 14. Labcompare
• 15. Luminex Corporation
• 16. Merck KGaA
• 17. Neogen Corporation
• 18. PerkinElmer, Inc.
• 19. QIAGEN N.V.
• 20. Randox Laboratories Ltd.
• 21. Siemens Healthineers AG
• 22. Sysmex Corporation
• 23. T2 Biosystems, Inc.
• 24. Thermo Fisher Scientific Inc.
• 25. Whitelake Software Point Oy